All lobbying filings

TIBER CREEK GROUP

Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Government relations.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 18, 2025

Official filing document

Bills named in this filing 1

HR 1672
Maintaining Investments in New Innovation Act

Lobbying activity 2

Medicare/Medicaid

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation (MINI) Act.

Health Issues

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340B Drug Pricing Program; General intellectual property issues; Issues related to drug pricing; Issues related to pharmacy benefit managers.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.